US › Healthcare

OrganiGram Holdings Inc (OGI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.99+2.94%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$59.8M
Revenue YoY
-8.9%
Net profit
$-921,000
Profit YoY
-102.2%
EPS
$-0.01
EPS estimate
$-0.00
Net margin
-1.5%

EPS came in at -0.01 against a street estimate of -0.00 — a miss of 45.7%.

Key statistics

Market cap
$135.8M
Forward P/E
40.0
P/B
0.50
Book value
$1.94
EPS (TTM)
$-0.15
52-week high
$2.24
52-week low
$0.85
50-day MA
$1.00
200-day MA
$1.40
Beta
1.85

Analyst view

Analysts rate OrganiGram Holdings Inc a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $8.80.

Shareholding

Insiders
30.26%
Institutions
6.63%

Largest institutional holders

FundStake
Tidal Investments LLC.1.54%
Renaissance Technologies Corp1.17%
AdvisorShares Investments, LLC0.67%
The Goldman Sachs Group Inc0.41%
Morgan Stanley - Brokerage Accounts0.26%
Lazard Asset Management LLC0.25%
Baader Bank INC0.19%
Bank of Montreal0.17%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for OrganiGram Holdings Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.